## Abstract We compared the antitremor effect of pramipexole, pergolide, or placebo in Parkinson's disease (PD). A doubleβblind, randomly controlled, parallel protocol was deployed to examine the effects of placebo, pergolide, and pramipexole [doses escalated to 1.5 mg three times daily (t.i.d.) ov
β¦ LIBER β¦
A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide
β Scribed by P. Navan; L. J. Findley; M. B. Undy; R. K. B. Pearce; P. G. Bain
- Book ID
- 111064258
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 165 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1351-5101
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Randomized, double-blind, 3-month parall
β
Prithiva Navan; Leslie J. Findley; Jim A.R. Jeffs; Ronald K.B. Pearce; Peter G.
π
Article
π
2003
π
John Wiley and Sons
π
English
β 91 KB
Double-blind, single-dose, cross-over st
β
Prithiva Navan; Leslie J. Findley; Jim A. R. Jeffs; Ronald K. B. Pearce; Peter G
π
Article
π
2003
π
John Wiley and Sons
π
English
β 140 KB
π 1 views
## Abstract Tremor is one of the cardinal signs of Parkinson's disease (PD) but its response to antiparkinsonian medication is variable. It has been postulated that pramipexole may have a stronger antiparkinsonian tremor effect than pergolide, another direct acting dopamine agonist medication, poss
Clinical trial: the effects of a probiot
β
M. Montalto; A. Gallo; V. Curigliano; F. DβOnofrio; L. Santoro; M. Covino; S. Da
π
Article
π
2010
π
John Wiley and Sons
π
English
β 182 KB